Kim E - Search Results

1

The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus.

Albrecht J, Taylor L, Berlin JA, Dulay S, Ang G, Fakharzadeh S, Kantor J, Kim E, Militello G, McGinnis K, Richardson S, Treat J, Vittorio C, Van Voorhees A, Werth VP. Albrecht J, et al. Among authors: kim e. J Invest Dermatol. 2005 Nov;125(5):889-94. doi: 10.1111/j.0022-202X.2005.23889.x. J Invest Dermatol. 2005. PMID: 16297185 Free PMC article.

2

Extracorporeal photopheresis and multimodality immunomodulatory therapy in the treatment of cutaneous T-cell lymphoma.

Richardson SK, McGinnis KS, Shapiro M, Lehrer MS, Kim EJ, Vittorio CC, Junkins Hopkins JM, Rook AH. Richardson SK, et al. J Cutan Med Surg. 2003 Jul-Aug;7(4 Suppl):8-12. doi: 10.1007/s10227-003-5002-0. J Cutan Med Surg. 2003. PMID: 12958701 No abstract available.

3

Low-dose bexarotene and low-dose interferon alfa-2b for adult T-cell leukemia/lymphoma associated with human T-lymphotropic virus 1.

Richardson S, Budgin JB, Junkins-Hopkins JM, Vittorio CC, Lee J, Miller WT Jr, Rook AH, Kim EJ. Richardson S, et al. Arch Dermatol. 2005 Mar;141(3):301-4. doi: 10.1001/archderm.141.3.301. Arch Dermatol. 2005. PMID: 15781670 No abstract available.

4

Immunopathogenesis and therapy of cutaneous T cell lymphoma.

Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M, Rook AH. Kim EJ, et al. J Clin Invest. 2005 Apr;115(4):798-812. doi: 10.1172/JCI24826. J Clin Invest. 2005. PMID: 15841167 Free PMC article. Review.

5

The addition of interferon gamma to oral bexarotene therapy with photopheresis for Sézary syndrome.

McGinnis KS, Ubriani R, Newton S, Junkins-Hopkins JM, Vittorio CC, Kim EJ, Wysocka M, Rook AH. McGinnis KS, et al. Arch Dermatol. 2005 Sep;141(9):1176-8. doi: 10.1001/archderm.141.9.1176. Arch Dermatol. 2005. PMID: 16172331 No abstract available.

6

Mycosis fungoides and sezary syndrome: an update.

Kim EJ, Lin J, Junkins-Hopkins JM, Vittorio CC, Rook AH. Kim EJ, et al. Curr Oncol Rep. 2006 Sep;8(5):376-86. doi: 10.1007/s11912-006-0061-1. Curr Oncol Rep. 2006. PMID: 16901399 Review.

7

High clinical response rate with multimodality immunomodulatory therapy for Sézary syndrome.

Richardson SK, Lin JH, Vittorio CC, Kim EJ, Yoon JS, Junkins-Hopkins J, Rook AH. Richardson SK, et al. Clin Lymphoma Myeloma. 2006 Nov;7(3):226-32. doi: 10.3816/CLM.2006.n.063. Clin Lymphoma Myeloma. 2006. PMID: 17229339 Clinical Trial.

8

Progressive multifocal leukoencephalopathy from JC virus in a patient with advanced mycosis fungoides.

Lee J, Richardson SK, Melhem ER, Rook AH, Kim EJ. Lee J, et al. J Am Acad Dermatol. 2007 Nov;57(5):893-5. doi: 10.1016/j.jaad.2007.06.025. Epub 2007 Aug 29. J Am Acad Dermatol. 2007. PMID: 17761357

9

Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.

Introcaso CE, Micaily B, Richardson SK, Junkins-Hopkins JM, Yoon JS, Kim EJ, Vittorio CC, Rook AH. Introcaso CE, et al. Among authors: kim ej. J Am Acad Dermatol. 2008 Apr;58(4):592-5. doi: 10.1016/j.jaad.2007.12.016. Epub 2008 Feb 4. J Am Acad Dermatol. 2008. PMID: 18249469

10

Stem cell transplantation in advanced cutaneous T-cell lymphoma.

Introcaso CE, Leber B, Greene K, Ubriani R, Rook AH, Kim EJ. Introcaso CE, et al. Among authors: kim ej. J Am Acad Dermatol. 2008 Apr;58(4):645-9. doi: 10.1016/j.jaad.2007.12.021. Epub 2008 Feb 6. J Am Acad Dermatol. 2008. PMID: 18258335 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

22,987 results

Search Page